TAMOXIFEN TREATMENT INDUCES PROTECTION IN MURINE CYSTICERCOSISVARGAS-VILLAVICENCIO, J. Antonio; LARRALDE, Carlos; DE LEON-NAVA, Marco A et al.The Journal of parasitology. 2007, Vol 93, Num 6, pp 1512-1517, issn 0022-3395, 6 p.Article

Evaluating Tamoxifen Effect in the Prevention of Hypertrophic Scars Following Surgical IncisionsSEYED REZA MOUSAVI; RAAISZADEH, Mohamad; AMINSERESHT, Mohamad et al.Dermatologic surgery. 2010, Vol 36, Num 5, pp 665-669, issn 1076-0512, 5 p.Article

Hypertriglycéridémie majeure sous tamoxiféne = Severe hypertriglyceridemia under tamoxifenLa Revue Prescrire. 1998, Vol 18, Num 183, pp 281-282, issn 0247-7750Article

Case 2. Tamoxifen and uterine abnormalitiesBUIJS, C; WILLEMSE, P. H. B; TINGA, D. J et al.Journal of clinical oncology. 2004, Vol 22, Num 12, pp 2505-2507, issn 0732-183X, 3 p.Article

Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actionsLONARD, David M; SMITH, Carolyn L.Steroids. 2002, Vol 67, Num 1, pp 15-24, issn 0039-128XArticle

Agonistic and synergistic activity of tamoxifen in a yeast model systemGRAUMANN, K; JUNGBAUER, A.Biochemical pharmacology. 2000, Vol 59, Num 2, pp 177-185, issn 0006-2952Article

The estrogen receptor modulator tamoxifen enhances spontaneous glycinergic synaptic inhibition of hypoglossal motoneuronsCHESNOY-MARCHAIS, D.Endocrinology (Philadelphia). 2005, Vol 146, Num 10, pp 4302-4311, issn 0013-7227, 10 p.Article

Effect of 4-hydroxytamoxifen isomers on growth and ultrastructural aspects of normal human breast epithelial (HBE) cells in cultureMALET, Catherine; SPRITZER, Poli; CUMINS, Caroline et al.Journal of steroid biochemistry and molecular biology. 2002, Vol 82, Num 4-5, pp 289-296, issn 0960-0760, 8 p.Article

Synergistic interactions between tamoxifen and trastuzumab (Herceptin)ARGIRIS, Athanassios; WANG, Chun-Xia; WHALEN, Steve G et al.Clinical cancer research. 2004, Vol 10, Num 4, pp 1409-1420, issn 1078-0432, 12 p.Article

Investigating abnormal bleeding on HRT or tamoxifen: the role of ultrasonographyFERRAZZI, Enrico; LEONE, F. P. G.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2004, Vol 18, Num 1, pp 145-156, issn 1521-6934, 12 p.Article

Neo adjuvant Tamoxifen in post menopausal patients with operable breast cancerSALMON, R. J; REMVIKOS, Y; CAMPANA, F et al.European journal of surgical oncology. 2003, Vol 29, Num 10, pp 831-834, issn 0748-7983, 4 p.Article

Intraocular penetration of TamoxifenFLAXEL, Christina J; MULHOLLAND, Bridget; HAYNES, Benjamin et al.Ophthalmology (Rochester, MN). 2000, Vol 107, Num 11, pp 2006-2009, issn 0161-6420Article

Reversible immortalization of rat pancreatic β cells with a novel immortalizing and tamoxifen-mediated self-recombination tricistronic vectorWU, Hui-Ling; YU WANG; BING CHEN et al.Journal of biotechnology. 2011, Vol 151, Num 3, pp 231-241, issn 0168-1656, 11 p.Article

Personalized Tamoxifen: A Step Closer but Miles To GoBARDIA, Aditya; STEARNS, Vered.Clinical cancer research (Print). 2010, Vol 16, Num 17, pp 4308-4310, issn 1078-0432, 3 p.Article

Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivitySHEKHAR, Malathy P. V; SANTNER, Steven; CAROLIN, Kathryn A et al.The American journal of pathology. 2007, Vol 170, Num 5, pp 1546-1560, issn 0002-9440, 15 p.Article

Un carcinome lobulaire infiltrant : que proposer après cinq ans de tamoxifène ?La Lettre du sénologue. 2006, Num 31, pp 33-34, issn 1289-2505, 2 p.Article

Hepatic DNA adduct dosimetry in rats fed tamoxifen : a comparison of methodsSCHILD, Laura J; PHILLIPS, David H; OSBORNE, Martin R et al.Mutagenesis. 2005, Vol 20, Num 2, pp 115-124, issn 0267-8357, 10 p.Article

Changes in bone mineral density during and after 3 years' use of tamoxifen or toremifeneTIITINEN, Aila; NIKANDER, Eini; HIETANEN, Päivi et al.Maturitas (Amsterdam). 2004, Vol 48, Num 3, pp 321-327, issn 0378-5122, 7 p.Article

Étude des interférences potentielles entre progestatifs et tamoxifène = Progestins and tamoxifen: interferenceNEVEN, P; LESUR, A.SFSPM : Société française de sénologie et de pathologie mammaire. Journées. 2004, pp 424-434, isbn 2-9520435-6-6, 11 p.Conference Paper

Involvement of PKA and Sp1 in the induction of p27^Kip1 by tamoxifenLEE, Te-Hsiu; CHANG, Hui-Chiu; CHUANG, Lea-Yea et al.Biochemical pharmacology. 2003, Vol 66, Num 3, pp 371-377, issn 0006-2952, 7 p.Article

Antimanic-like effect of tamoxifen is not reproduced by acute or chronic administration of medroxyprogesterone or clomiphenePEREIRA, Marcela; JACSON MARTYNHAK, Bruno; PAULINA BARETTA, Irinéia et al.Neuroscience letters. 2011, Vol 500, Num 2, pp 95-98, issn 0304-3940, 4 p.Article

An uncertainty and sensitivity analysis applied to the prioritisation of pharmaceuticals as surface water contaminants from wastewater treatment plant direct emissionsMORAIS, Sérgio Alberto; DELERUE-MATOS, Cristina; GABARRELL, Xavier et al.Science of the total environment. 2014, Vol 490, pp 342-350, issn 0048-9697, 9 p.Article

Changes in serum hydroxyvitamin D levels of breast cancer patients during tamoxifen treatment or chemotherapy in premenopausal breast cancer patientsHEE JEONG KIM; BEOM SEOK KOH; JONG HAN YU et al.European journal of cancer (1990). 2014, Vol 50, Num 8, pp 1403-1411, issn 0959-8049, 9 p.Article

Delayed triggering of oestrogen induced apoptosis that contrasts with rapid paclitaxel-induced breast cancer cell deathOBIORAH, I; SENGUPTA, S; FAN, P et al.British journal of cancer. 2014, Vol 110, Num 6, pp 1488-1496, issn 0007-0920, 9 p.Article

Impact of variable CYP genotypes on breast cancer relapse in patients undergoing adjuvant tamoxifen therapyMWINYI, Jessica; VOKINGER, Kerstin; JETTER, Alexander et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 6, pp 1181-1188, issn 0344-5704, 8 p.Article